Skip to content
Oncol Rep· Oncology reports·· 2 days agoPickScore36

PBRM1 knockdown is associated with NRF2‑dependent ALDOA upregulation and metabolic reprogramming in HCCC‑9810 intrahepatic cholangiocarcinoma cells

PBRM1 knockdown is associated with NRF2‑dependent ALDOA upregulation and metabolic reprogramming in HCCC‑9810 intrahepatic cholangiocarcinoma cells

In brief

PBRM1 knockdown made HCCC-9810 intrahepatic cholangiocarcinoma cells more proliferative, migratory and invasive, altered glucose-metabolism readouts, and raised aldolase A (ALDOA) expression. ALDOA silencing attenuated several metabolic and survival-related changes, and NRF2 overexpression increased ALDOA while NRF2 knockdown reduced it, indicating NRF2-dependent ALDOA regulation. In HCCC-9810-derived xenografts, PBRM1 knockdown produced greater tumor growth, higher ALDOA expression and higher Ki67 signal.

Why it matters

Links a chromatin-remodeling factor altered in ICC to NRF2-dependent ALDOA metabolic reprogramming and tumor growth.

Source: Oncol Rep · pubmed.ncbi.nlm.nih.gov

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org